
Genmab A/S
NASDAQ:GMAB

Wall Street
Price Targets
GMAB Price Targets Summary
Genmab A/S
According to Wall Street analysts, the average 1-year price target for
GMAB
is 117.17 USD
with a low forecast of 15.45 USD and a high forecast of 265.22 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is GMAB's stock price target?
Price Target
117.17
USD
According to Wall Street analysts, the average 1-year price target for
GMAB
is 117.17 USD
with a low forecast of 15.45 USD and a high forecast of 265.22 USD.
What is Genmab A/S's Revenue forecast?
Projected CAGR
117%
For the last 8 years the
compound annual growth rate for
Genmab A/S's revenue is
8%.
The projected
CAGR
for the next 3 years is
117%.
What is Genmab A/S's Operating Income forecast?
Projected CAGR
123%
For the last 8 years the
compound annual growth rate for
Genmab A/S's operating income is
0%.
The projected
CAGR
for the next 3 years is
123%.
What is Genmab A/S's Net Income forecast?
Projected CAGR
104%
For the last 8 years the
compound annual growth rate for
Genmab A/S's net income is
0%.
The projected
CAGR
for the next 3 years is
104%.